These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 15961997)

  • 1. Nuclear speckles and nucleoli targeting by PIP2-PDZ domain interactions.
    Mortier E; Wuytens G; Leenaerts I; Hannes F; Heung MY; Degeest G; David G; Zimmermann P
    EMBO J; 2005 Jul; 24(14):2556-65. PubMed ID: 15961997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDZ domain-phosphoinositide interactions in cell-signaling.
    Zimmermann P
    Verh K Acad Geneeskd Belg; 2006; 68(4):271-86. PubMed ID: 17214441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The characterization of the nuclear dynamics of syntenin-2, a PIP2 binding PDZ protein.
    Geeraerts A; Hsiu-Fang F; Zimmermann P; Engelborghs Y
    Cytometry A; 2013 Sep; 83(9):866-75. PubMed ID: 23300061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syndecan recycling [corrected] is controlled by syntenin-PIP2 interaction and Arf6.
    Zimmermann P; Zhang Z; Degeest G; Mortier E; Leenaerts I; Coomans C; Schulz J; N'Kuli F; Courtoy PJ; David G
    Dev Cell; 2005 Sep; 9(3):377-88. PubMed ID: 16139226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence and significance of PDZ domain-phosphoinositide interactions.
    Zimmermann P
    Biochim Biophys Acta; 2006 Aug; 1761(8):947-56. PubMed ID: 16884951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural insights into the PIP2 recognition by syntenin-1 PDZ domain.
    Sugi T; Oyama T; Morikawa K; Jingami H
    Biochem Biophys Res Commun; 2008 Feb; 366(2):373-8. PubMed ID: 18062914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PIP(2)-PDZ domain binding controls the association of syntenin with the plasma membrane.
    Zimmermann P; Meerschaert K; Reekmans G; Leenaerts I; Small JV; Vandekerckhove J; David G; Gettemans J
    Mol Cell; 2002 Jun; 9(6):1215-25. PubMed ID: 12086619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neuronal glycine transporter 2 interacts with the PDZ domain protein syntenin-1.
    Ohno K; Koroll M; El Far O; Scholze P; Gomeza J; Betz H
    Mol Cell Neurosci; 2004 Aug; 26(4):518-29. PubMed ID: 15276154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The binding of the PDZ tandem of syntenin to target proteins.
    Grembecka J; Cierpicki T; Devedjiev Y; Derewenda U; Kang BS; Bushweller JH; Derewenda ZS
    Biochemistry; 2006 Mar; 45(11):3674-83. PubMed ID: 16533050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tandem PDZ domains of syntenin promote cell invasion.
    Meerschaert K; Bruyneel E; De Wever O; Vanloo B; Boucherie C; Bracke M; Vandekerckhove J; Gettemans J
    Exp Cell Res; 2007 May; 313(9):1790-804. PubMed ID: 17451681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syntenin-syndecan binding requires syndecan-synteny and the co-operation of both PDZ domains of syntenin.
    Grootjans JJ; Reekmans G; Ceulemans H; David G
    J Biol Chem; 2000 Jun; 275(26):19933-41. PubMed ID: 10770943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The complexity of PDZ domain-mediated interactions at glutamatergic synapses: a case study on neuroligin.
    Meyer G; Varoqueaux F; Neeb A; Oschlies M; Brose N
    Neuropharmacology; 2004 Oct; 47(5):724-33. PubMed ID: 15458844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Making protein interactions druggable: targeting PDZ domains.
    Dev KK
    Nat Rev Drug Discov; 2004 Dec; 3(12):1047-56. PubMed ID: 15573103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIP2 increases the speed of response of synaptotagmin and steers its membrane-penetration activity toward the plasma membrane.
    Bai J; Tucker WC; Chapman ER
    Nat Struct Mol Biol; 2004 Jan; 11(1):36-44. PubMed ID: 14718921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frizzled 7 and PIP2 binding by syntenin PDZ2 domain supports Frizzled 7 trafficking and signalling.
    Egea-Jimenez AL; Gallardo R; Garcia-Pino A; Ivarsson Y; Wawrzyniak AM; Kashyap R; Loris R; Schymkowitz J; Rousseau F; Zimmermann P
    Nat Commun; 2016 Jul; 7():12101. PubMed ID: 27386966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretory carrier membrane protein SCAMP2 and phosphatidylinositol 4,5-bisphosphate interactions in the regulation of dense core vesicle exocytosis.
    Liao H; Ellena J; Liu L; Szabo G; Cafiso D; Castle D
    Biochemistry; 2007 Sep; 46(38):10909-20. PubMed ID: 17713930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of syntenin, a syndecan-binding PDZ protein, as a component of cell adhesion sites and microfilaments.
    Zimmermann P; Tomatis D; Rosas M; Grootjans J; Leenaerts I; Degeest G; Reekmans G; Coomans C; David G
    Mol Biol Cell; 2001 Feb; 12(2):339-50. PubMed ID: 11179419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tandem PDZ protein Syntenin interacts with the aminoacyl tRNA synthetase complex in a lysyl-tRNA synthetase-dependent manner.
    Meerschaert K; Remue E; De Ganck A; Staes A; Boucherie C; Gevaert K; Vandekerckhove J; Kleiman L; Gettemans J
    J Proteome Res; 2008 Nov; 7(11):4962-73. PubMed ID: 18839981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syntenin: a novel PDZ domain-containing scaffolding protein associated with human melanoma metastasis.
    Yang JB; McCarthy JB
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):204-12. PubMed ID: 17478924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lymphocyte receptor CD6 interacts with syntenin-1, a scaffolding protein containing PDZ domains.
    Gimferrer I; Ibáñez A; Farnós M; Sarrias MR; Fenutría R; Roselló S; Zimmermann P; David G; Vives J; Serra-Pagès C; Lozano F
    J Immunol; 2005 Aug; 175(3):1406-14. PubMed ID: 16034076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.